Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Naftali Kaminski

Interstitial Lung Disease · Yale College

View

Dr. Auston Stiefer

Interstitial Lung Disease · CU Anschutz Medical Campus

View

Dr. Imre Noth

Interstitial Lung Disease · University of Virginia

View

Dr. Cedric “Jamie” Rutland

Interstitial Lung Disease · Private Practice

View

Dr. Justin Zhang

Critical Care · UCLA

View

Dr. Panagis Galiatsatos

Critical Care · Johns Hopkins

View

Dr. MeiLan Han

Asthma & COPD · UMHS

View

Dr. Kevin Chung

Critical Care · SeaStar Medical

View

Dr. Diego J. Maselli

Asthma & COPD · UTHSCSA

View

Dr. Amos E. Dodi

Critical Care · MMC

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    FMDr. Fernando Martinez

    Dr. Fernando Martinez

    Pulmonology & Critical Care · Interstitial Lung Diseases
    University of Massachusetts Chan Medical School
    fernando

    Research

    Efficacy and Safety of Admilparant, an LPA₁ Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial

    2025

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Proteomic Biomarkers of Survival in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease

    2025

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Associations of Interstitial Lung Disease Subtype and CT Pattern with Lung Function and Survival

    2025

    Via Thorax

    Research

    Adaptive Multi-Interventional Trial Platform to Improve Patient Care for Fibrotic Interstitial Lung Diseases (REMAP-ILD)

    2024

    Via Thorax

    Research

    Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Zinpentraxin Alfa for Idiopathic Pulmonary Fibrosis: The Randomized Phase III STARSCAPE Trial

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine

    2024

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Clonal Somatic Mutations in Chronic Lung Diseases Are Associated with Reduced Lung Function

    2023

    Via American Journal of Respiratory and Critical Care Medicine

    Research

    Design of a Phase III, Double-Blind, Randomised, Placebo-Controlled Trial of BI 1015550 in Patients with Progressive Pulmonary Fibrosis (FIBRONEER-ILD)

    2023

    Via BMJ Open Respiratory Research